Regional
Region X EMS
An undated version is under review. The figures below are from the current listed document.
Drugs and doses27
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine5
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 20 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 81, 82 |
| SVT | adult | 6 mg | IV | not captured | standing | pages 20, 81, 82 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 20, 81, 82 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 30, 36, 86, 92, 102 |
| Crush injury | adult | 2.5 mg | NEB | not captured | standing | page 59 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 30 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 30 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 86 |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 111, 112, 113 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 86 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 125 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 125 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 24 |
| Other | adult | 150 mg | IV/IO | not captured | standing | page 125 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 111 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 112 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 113 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 114 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 125 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | pages 21, 81, 82 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | pages 21, 81, 82 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 24, 84 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 24, 84 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 16 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 43 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 44 |
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 18, 79, 128 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 18, 79, 128 |
| Other | adult | 2 mg | IM | not captured | standing | pages 41, 131 |
| Other | adult | 2–4 mg | IM | not captured | standing | pages 41, 131 |
| Other | peds | 0.05 mg/kg | IM | not captured | standing | pages 41, 131 |
| Other | peds | 0.05 mg/kg | IM | not captured | standing | pages 41, 131 |
D–F Dextrose, Diphenhydramine, Epinephrine, Etomidate, Fentanyl5
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 38, 95, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 38, 95, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 95 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | IV/IO | not captured | standing | pages 36, 92, 93, 130 |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | pages 36, 92, 93, 130 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO | not captured | standing | pages 36, 92, 93, 130 |
| Anaphylaxis | peds | 1 mg/kg | IM | not captured | standing | pages 36, 92, 93, 130 |
| Other | adult | 25 mg | IV | not captured | standing | pages 36, 93, 130 |
| Other | adult | 25 mg | IM | not captured | standing | pages 36, 93, 130 |
| Other | adult | 25 mg | IV | not captured | standing | pages 36, 93, 130 |
| Other | adult | 50 mg | IV/IO | not captured | standing | pages 36, 92, 130 |
| Other | adult | 50 mg | IV | not captured | standing | pages 36, 92 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 36, 93, 130 |
| Other | peds | 1 mg/kg | IM | not captured | standing | pages 36, 93, 130 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 36, 92, 130 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 36, 92 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 36, 93, 130 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | page 36 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 30 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 86 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 79 |
| Other | adult | 0.3 mg | IM | not captured | standing | page 30 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 92 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 79 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 86 |
| Other | peds | 0.01 mg/kg | IM | not captured | standing | page 92 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 112, 113, 114, 115, 116, 117, 118, 134, 154 |
| Other | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 112, 113, 114, 115, 116, 117, 118, 134, 154 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 134, 154 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 134, 154 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 16, 17, 18, 20, 21, 48, 57, 58, 63, 65, 70, 81, 82, 98, 109, 135 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 16, 17, 18, 20, 21, 48, 57, 58, 63, 65, 70, 81, 82, 98, 109, 135 |
G–L Glucagon, Hydralazine, Hydroxocobalamin, Ipratropium, Ketamine, Lidocaine6
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV | not captured | standing | pages 43, 136 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 38, 95, 136 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 38, 95, 136 |
| Hypoglycemia | peds | 1 mg | IM/IN | not captured | standing | pages 38, 95, 136 |
| Other | adult | 1 mg | IM/IN | not captured | standing | pages 38, 136 |
| Other | adult | 1 mg | IV/IO | not captured | standing | pages 43, 136 |
| Other | peds | 0.5 mg | IM/IN | not captured | standing | pages 95, 136 |
| Other | peds | 0.5 mg | IM/IN | not captured | standing | pages 111, 112, 113, 114, 115, 116 |
| Other | peds | 1 mg | IM/IN | not captured | standing | pages 95, 136 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV/IO | not captured | standing | pages 78, 138 |
| Other | adult | 5 mg | IV | not captured | standing | pages 78, 138 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 177 |
| Other | adult | 5 g | IV | not captured | standing | page 177 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 36, 92, 139 |
| Allergic reaction | peds | 0.5 mg | NEB | not captured | standing | pages 36, 92, 139 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 30, 139 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 86, 139 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 30, 139 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 86, 139 |
| Other | adult | 0.5 mg | NEB | not captured | standing | pages 92, 139 |
| Other | peds | 0.5 mg | NEB | not captured | standing | pages 92, 139 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 4 mg/kg | IM | not captured | standing | pages 14, 15, 46, 47 |
| Other | adult | 23 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | adult | 45 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | adult | 90 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | adult | 100 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | adult | 25 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | adult | 50 mg | IV/IO | not captured | standing | pages 33, 34 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 88, 89, 140 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 88, 89, 140 |
| Post-intubation sedation | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 33, 34, 88, 89, 140 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | pages 33, 34, 88, 89, 140 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IO | not captured | standing | pages 143, 162 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 112 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 113 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 114 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 115 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 116 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 117 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 118 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 143, 162 |
| Mild to moderate pain | adult | 1 mg/kg | IO | not captured | standing | pages 143, 162 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | pages 143, 162 |
M–O Magnesium Sulfate, Midazolam, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Ondansetron, Oral Glucose7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 30, 144 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV | not captured | standing | pages 30, 144 |
| Other | adult | 2 g | IV | not captured | standing | page 30 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 144 |
| Other | adult | 4 g | IV | not captured | standing | pages 78, 145 |
| Other | peds | 25 mg/kg | IV/IO | not captured | standing | page 144 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | pages 21, 84, 144 |
| Wide-complex tachycardia | peds | 25 mg/kg | IV | not captured | standing | pages 21, 84, 144 |
| VF / pulseless VT | peds | 25 mg/kg | IV | not captured | standing | pages 24, 84, 144 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO/IM/IN | not captured | standing | pages 14, 15, 46 |
| Other | adult | 2 mg | IV/IO | not captured | standing | pages 17, 20, 21, 81, 82 |
| Other | peds | 0.2 mg/kg | IV/IO | not captured | standing | pages 17, 20, 21, 81, 82 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO | not captured | standing | page 18 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 49, 99, 146 |
| Seizure | adult | 2 mg | IV/IO/IN | not captured | standing | pages 49, 99, 146 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 49, 99, 146 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IN | not captured | standing | pages 49, 99, 146 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 45, 97, 147 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 45, 97, 147 |
| Mild to moderate pain | adult | 2 mg | IM/IN | not captured | standing | pages 48, 98 |
| Mild to moderate pain | adult | 2 mg | IV/IO | not captured | standing | pages 48, 98 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 48, 98 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 48, 98 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 2–4 mg | IM | not captured | standing | page 131 |
| Other | adult | 2.1 mg | IM | not captured | standing | page 131 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 16 |
| CHF / pulmonary edema | adult | 1.2 mg | SL | not captured | standing | page 32 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | pages 40, 96, 150 |
| Nausea / vomiting | adult | 4 mg | PO | not captured | standing | pages 40, 96, 150 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | pages 40, 96, 150 |
| Nausea / vomiting | peds | 4 mg | IV | not captured | standing | pages 40, 96, 150 |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | pages 40, 96, 150 |
| Nausea / vomiting | peds | 4 mg | IV/IO | not captured | standing | page 96 |
| Mild to moderate pain | adult | 4 mg | IV/IO | not captured | standing | pages 48, 98 |
| Mild to moderate pain | adult | 4 mg | PO | not captured | standing | pages 48, 98 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 48, 98 |
| Mild to moderate pain | peds | 4 mg | IV/IO | not captured | standing | pages 48, 98 |
| Mild to moderate pain | peds | 4 mg | PO | not captured | standing | pages 48, 98 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 38, 95 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | pages 95, 137 |
P–R Pralidoxime1
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 600 mg | IM | not captured | standing | pages 41, 131 |
| Organophosphate poisoning | peds | 10 mg/kg | IM | not captured | standing | pages 41, 131 |
| Organophosphate poisoning | peds | 15 mg/kg | IM | not captured | standing | pages 41, 131 |
| Other | adult | 1800 mg | IM | not captured | standing | pages 41, 131 |
| Other | adult | 600 mg | IM | not captured | standing | pages 41, 131 |
| Other | peds | 15 mg/kg | IM | not captured | standing | pages 41, 131 |
| Other | peds | 45 mg/kg | IM | not captured | standing | pages 41, 131 |
S–Z Sodium Bicarbonate, Tranexamic Acid, Verapamil3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 50 mEq | IV/IO | not captured | standing | page 23 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 50 mEq | IV/IO | not captured | standing | page 43 |
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 59 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | page 151 |
| VF / pulseless VT | adult | 50 mEq | IV/IO | not captured | standing | page 24 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | pages 73, 77, 152 |
| Other | adult | 1 g | IV | not captured | standing | page 63 |
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | pages 63, 152 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | page 17 |
| Other | adult | 5 mg | IV/IO | not captured | standing | page 153 |
| SVT | adult | 5 mg | IV | not captured | standing | page 20 |
Cite this
Region X EMS, United States EMS Protocol Census. 166 dose entries, effective 2026-05-25.
https://protoquiz.com/census/agencies/region-x-ems/
The census is free and not for sale. Only public agencies are named.